Keywords: گاستروانترپانکراسی; Neuroendocrine; Neoplasms; Carcinoma; Digestive; Gastroenteropancreatic; NET G3; NEC;
مقالات ISI گاستروانترپانکراسی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Evaluating bevacizumab in combination with FOLFIRI after the failure of platinum-etoposide regimen in patients with advanced poorly differentiated neuroendocrine carcinoma: The PRODIGE 41-BEVANEC randomized phase II study
Keywords: گاستروانترپانکراسی; Bevacizumab; Clinical trial; FOLFIRI; Gastroenteropancreatic; Neuroendocrine carcinoma;
High interlaboratory and interobserver agreement of somatostatin receptor immunohistochemical determination and correlation with response to somatostatin analogs
Keywords: گاستروانترپانکراسی; SSTR; somatostatin receptor; NEN; neuroendocrine neoplasms; SRS; somatostatin receptor scintigraphy; GI; gastrointestinal; GEP; gastroenteropancreatic; NET; neuroendocrine tumor; NEC; neuroendocrine carcinoma; PR; partial response; SD; stable disease; PD;
The expression of TTF1, CDX2 and ISL1 in 74 poorly differentiated neuroendocrine carcinomas
Keywords: گاستروانترپانکراسی; Neuroendocrine carcinoma; Lung; Gastroenteropancreatic; Immunohistochemistry; TTF1; CDX2;
Chemotherapy in gastroenteropancreatic (GEP) neuroendocrine carcinomas (NEC): A critical view
Keywords: گاستروانترپانکراسی; Chemotherapy; Neuroendocrine carcinoma; NEC; NET; GEP; Gastroenteropancreatic; Cisplatin; Etoposide; Carboplatin; Irinotecan
11Selecting patients for cytotoxic therapies in gastroenteropancreatic neuroendocrine tumours
Keywords: گاستروانترپانکراسی; Gastroenteropancreatic; Neuroendocrine tumour; Carcinoid; Pancreatic; Chemotherapy;
Plasma Chromogranin A as Marker for Survival in Patients With Metastatic Endocrine Gastroenteropancreatic Tumors
Keywords: گاستروانترپانکراسی; CgA; chromogranin A; CI; confidence interval; CT; computed tomography; GEP; gastroenteropancreatic; MRI; magnetic resonance imaging;
Therapeutic Options for Gastrointestinal Carcinoids
Keywords: گاستروانترپانکراسی; CTGF; connective tissue growth factor; 5-FU; 5-fluorouracil; GEP; gastroenteropancreatic; HDAC; histone deacetylase; 5-HIIA; 5-hydroxyindoleacetic acid; IFN; interferon; LAR; long-acting repeatable; 131I-MIBG; Iodine-131-Meta-Iodobenzylguanidine; NET; neu
Radioembolization with Yttrium-90 Microspheres: A State-of-the-Art Brachytherapy Treatment for Primary and Secondary Liver Malignancies
Keywords: گاستروانترپانکراسی; AFP; α-fetoprotein; CEA; carcinoembryonic antigen; ECOG; Eastern Cooperative Oncology Group; FDG; [18F]fluorodeoxyglucose; 5-FU; 5-fluorouracil; GEP; gastroenteropancreatic; HAC; hepatic artery chemotherapy; HCC; hepatocellular carcinoma; PET; positron e
Enteroendocrine Tumors Other Than Carcinoid: A Review of Clinically Significant Advances
Keywords: گاستروانترپانکراسی; APUD; Amine precursor uptake and decarboxylation; CgA; chromogranin-A; GEP; gastroenteropancreatic; MEN-1; multiple endocrine neoplasia syndrome 1; NET; neuroendocrine tumor; PET; pancreatic endocrine tumor; SRS; somatostatin receptor scintigraphy; SST; s
Current Status of Gastrointestinal Carcinoids
Keywords: گاستروانترپانکراسی; 5-HIAA; 5-hydroxyindoleacetic acid; 5-HT; 5-hydroxytryptophan; ACTH; adrenocorticotropic hormone; AFP; α-fetoprotein; AP-1; activator protein-1 complex; CAG/A; chronic atrophic gastritis-type A; CBD; common bile duct; CCD; carcinoid cardiac disease; CEA;